One positive sign was that Vertex raised the lower end of its forecast for full-year 2025 revenue by $100 million. The ...

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 13 cents per share. The company posted revenue of $177.1 ...

Vertex, Inc. (VERX) kicks off 2025 strong with 12.9% revenue growth, strategic AI investments, and e-invoicing innovations.

Vertex said its profit fell due to higher operating expenses and a $379 million intangible asset impairment charge associated with treatment for Type 1 diabetes patients, which the company said in ...

A decade has passed since a short-lived railcar manufacturer opened its doors in Wilmington. At an invitation-only event in November 2014, many promises were made on behalf of Vertex Rail Technologies ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

William Blair just gave Vertex Pharmaceuticals a shiny bump in its 2025 earnings forecast, increasing EPS to $16.20 from ...

Vertex Pharmaceuticals took a confidence hit as Leerink Partners downgraded the stock from “strong-buy” to a mere “hold,” ...

The topics covered include complexity of approximation algorithms, new polynomial time algorithms for convex quadratic minimization, interior point algorithms, complexity issues regarding test ...